Latest Buy Back Programs News

Carlton Investments lifted its profit by 6.1% to $41.18 million for FY2026, boosted by higher dividends, even as its equity portfolio value fell 6.2%. The company declared a final dividend increase including a special payout amid ongoing market volatility.

Regal Partners Global Investments (ASX:RG1) reversed last year's losses with a $141.6 million net profit, driven by strong returns in semiconductors, gold, and European banks. The company declared a fully franked final dividend of 5.0 cents per share and continued its on-market share buy-back program.

Whitefield Industrials (ASX:WHF) has transitioned to quarterly dividend payments, declaring fully franked dividends for June 2026 that imply a 6.4% annual yield on its recent share price.

Cogstate Ltd (ASX:CGS) posted a 15.9% rise in profit before tax to US$16.1 million for FY26, driven by a 116% surge in clinical trial sales contracts to $89 million and a 15% revenue increase. The company doubled its final dividend to A$0.04 per share, supported by a strong $118.5 million contracted revenue backlog.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Challenger Limited delivered a solid FY26 with normalised net profit after tax rising 3% to $468 million, supported by record annuity sales and strategic partnerships. The company also declared a 7% higher fully franked dividend and announced an upsized $450 million share buy-back.

Region Group (ASX: RGN) delivered solid FY26 results with a 3.2% increase in Funds From Operations per security, a 9.8% total security holder return, and a leadership change as Greg Chubb took the helm as CEO.

Reliance Worldwide Corporation has agreed to an exclusivity period with Brookfield Capital Partners over a A$4.75 per share acquisition proposal, valuing the company at around A$4.1 billion. The deal includes a 30-day go-shop provision allowing alternative bids.

Regal Asian Investments (ASX:RG8) posted a stellar FY26 with a net profit after tax of $124.8 million, driven by a 52.6% net portfolio return and a 10 cent fully franked final dividend, reflecting strong exposure to Asian semiconductors amid the AI boom.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

Surefire Resources is initiating an on-market share buy-back of up to 15 million shares, about 8.3% of its issued capital, aiming to correct what it sees as a significant undervaluation relative to its gold assets.

Microequities Asset Management Group saw a 20.1% drop in profit after tax for FY26, hit by sharp valuation falls in tech-heavy portfolios amid AI fears, despite a 1.5% revenue rise and a strong balance sheet.